Zydus Cadila Covid-19 Vaccine Zycov-d
- All
- News
- Videos
- Web Stories
-
Zydus Cadila Begins Supply Of Covid Vaccine ZyCoV-D To Government
Pharmaceutical company Zydus on Wednesday announced that it has started the supplies of its COVID-19 vaccine ZyCoV-D to the Government of India against their order from its newly commissioned state-of-the-art.
-
Zydus Cadila's Covid Vaccine ZyCoV-D To Be Used In 7 States Initially
Zydus Cadila's Covid vaccine ZyCoV-D will initially be used in 7 states, including Maharashtra, Tamil Nadu, UP and Bengal, which have been recommended to identify the districts with a high number of people who have not received a single dose yet.
-
India To Buy 1 Crore Zydus Cadila 'Needle-Free' Covid Shots At Rs 265 Each
The indigenously developed world's first DNA-based needle-free COVID-19 vaccine ZyCoV-D received emergency use authorisation from the drug regulator on August 20.
-
60 Lakh Doses Of Zydus Cadila's Vaccine Ready After Production In October: Report
As many as 60 lakh doses of Zydus Cadila's three-dose COVID-19 vaccine ZyCoV-D are ready after production, said government sources.
-
Decision On Zydus Cadila's Vaccine Prices Soon, Says NITI Aayog
The discussion on the pricing of Zydus Cadila's COVID-19 vaccine ZyCoV-D is underway, said Dr VK Paul, Member (Health) NITI Aayog on Tuesday.
-
Zydus Cadila Says "More Clarity" On Its Covid Vaccine Price By Next Week
There will be more clarity on the prices of COVID-19 vaccine ZyCOV-D by next week, Zydus Group Managing Director Dr Sharvil Patel said today.
-
1st Covid Vaccine For Children Above 12 Approved In India
India's drug regulator on Friday approved Zydus Cadila's three-dose COVID-19 DNA vaccine for emergency use in adults and children aged 12 years and above, bringing in the sixth vaccine authorised for use in the country.
-
India's Zydus Cadila Seeks Nod For Its 3-Dose, "Needle-Free" Vaccine
Zydus Cadila has requested emergency use approval for its ZyCoV-D three-dose Covid shot that is the "world's first Plasmid DNA vaccine". The shot is "needle-free", says the company, and "safe for children".
-
Zydus Cadila Applies For Emergency Use Nod For Covid-19 Vaccine
An approval for Zydus' vaccine, ZyCoV-D, would make it the fifth vaccine authorized for use in the country.
-
Stocks To Watch: Cadila Healthcare, SpiceJet, Vodafone Idea
Zydus Cadila has applied for Emergency Use Authorization to the office of Drug Controller General of India for ZyCoV-D - its Plasmid DNA vaccine against COVID-19
-
India's Zydus Cadila Seeks Nod For Its Covid Vaccine ZyCoV-D
Indian drugmaker Zydus Cadila said on Thursday it has applied to the country's drug regulator for emergency use approval of its COVID-19 vaccine and that it plans to manufacture up to 120 million doses of the shot annually.
-
Zydus Cadila May Seek Emergency Use Approval For Vaccine Next Week: Report
Indian pharmaceutical major Zydus Cadila is likely to apply to the central drugs regulator seeking emergency use authorisation for its COVID-19 vaccine ZyCoV-D next week, official sources said on Friday.
-
Zydus Cadila's COVID-19 Vaccine Candidate Found Safe In Early-Stage Human Trial
Zydus plans to complete late-stage trials for ZyCoV-D by February or March and could produce up to 100 million doses a year initially.
-
Cadila Aims To Complete Trial Of Coronavirus Vaccine By March
Coronavirus vaccine: Early-stage Phase 1 and 2 human trials are likely to be concluded in the next three months
-
Zydus Cadila Begins Supply Of Covid Vaccine ZyCoV-D To Government
Pharmaceutical company Zydus on Wednesday announced that it has started the supplies of its COVID-19 vaccine ZyCoV-D to the Government of India against their order from its newly commissioned state-of-the-art.
-
Zydus Cadila's Covid Vaccine ZyCoV-D To Be Used In 7 States Initially
Zydus Cadila's Covid vaccine ZyCoV-D will initially be used in 7 states, including Maharashtra, Tamil Nadu, UP and Bengal, which have been recommended to identify the districts with a high number of people who have not received a single dose yet.
-
India To Buy 1 Crore Zydus Cadila 'Needle-Free' Covid Shots At Rs 265 Each
The indigenously developed world's first DNA-based needle-free COVID-19 vaccine ZyCoV-D received emergency use authorisation from the drug regulator on August 20.
-
60 Lakh Doses Of Zydus Cadila's Vaccine Ready After Production In October: Report
As many as 60 lakh doses of Zydus Cadila's three-dose COVID-19 vaccine ZyCoV-D are ready after production, said government sources.
-
Decision On Zydus Cadila's Vaccine Prices Soon, Says NITI Aayog
The discussion on the pricing of Zydus Cadila's COVID-19 vaccine ZyCoV-D is underway, said Dr VK Paul, Member (Health) NITI Aayog on Tuesday.
-
Zydus Cadila Says "More Clarity" On Its Covid Vaccine Price By Next Week
There will be more clarity on the prices of COVID-19 vaccine ZyCOV-D by next week, Zydus Group Managing Director Dr Sharvil Patel said today.
-
1st Covid Vaccine For Children Above 12 Approved In India
India's drug regulator on Friday approved Zydus Cadila's three-dose COVID-19 DNA vaccine for emergency use in adults and children aged 12 years and above, bringing in the sixth vaccine authorised for use in the country.
-
India's Zydus Cadila Seeks Nod For Its 3-Dose, "Needle-Free" Vaccine
Zydus Cadila has requested emergency use approval for its ZyCoV-D three-dose Covid shot that is the "world's first Plasmid DNA vaccine". The shot is "needle-free", says the company, and "safe for children".
-
Zydus Cadila Applies For Emergency Use Nod For Covid-19 Vaccine
An approval for Zydus' vaccine, ZyCoV-D, would make it the fifth vaccine authorized for use in the country.
-
Stocks To Watch: Cadila Healthcare, SpiceJet, Vodafone Idea
Zydus Cadila has applied for Emergency Use Authorization to the office of Drug Controller General of India for ZyCoV-D - its Plasmid DNA vaccine against COVID-19
-
India's Zydus Cadila Seeks Nod For Its Covid Vaccine ZyCoV-D
Indian drugmaker Zydus Cadila said on Thursday it has applied to the country's drug regulator for emergency use approval of its COVID-19 vaccine and that it plans to manufacture up to 120 million doses of the shot annually.
-
Zydus Cadila May Seek Emergency Use Approval For Vaccine Next Week: Report
Indian pharmaceutical major Zydus Cadila is likely to apply to the central drugs regulator seeking emergency use authorisation for its COVID-19 vaccine ZyCoV-D next week, official sources said on Friday.
-
Zydus Cadila's COVID-19 Vaccine Candidate Found Safe In Early-Stage Human Trial
Zydus plans to complete late-stage trials for ZyCoV-D by February or March and could produce up to 100 million doses a year initially.
-
Cadila Aims To Complete Trial Of Coronavirus Vaccine By March
Coronavirus vaccine: Early-stage Phase 1 and 2 human trials are likely to be concluded in the next three months
